biography About Jean-Claude Chermann
A pioneer in the study of retroviruses, he have been involved surrounded by many aspects of HIV research since he collaborated within the first isolation and characterization of the virus. He is currently Research & Development Director of URRMA R&D, Aubagne, France. URRMA R&D is a wholly owned subsidiary of URRMA Biopharma Inc., an emergent international company formed contained by June 1999 to develop and commercialize innovative HIV diagnostics and treatments that relate to anti-R7V technology.
Address correspondence to: urrma@urrma.
Wednesday, November 30, 2011
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment